To systematically investigate whether TKI-insensitive EGFR signaling is critical for NSCLCs, we analyzed the EGFR expression by evaluating DNA copy number (CN) and mRNA expression levels in LUAD and LUSC cohorts from The Cancer Genome Atlas (TCGA) NSCLC dataset. This evidence concerns the gene EGFR and non-small cell lung carcinoma.